DEVELOPMENT OF A NEW CLASS OF DRUGS TO INHIBIT ALL FORMS OF ANDROGEN RECEPTOR IN CASTRATION-RESISTANT PROSTATE CANCERS

Hauptman Woodward Medical Research Institute, Inc

Investigators